| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/24/2011 | US20110044949 Oncolytic virus replicating selectively in tumor cells |
| 02/24/2011 | US20110044948 Poxviral oncolytic vectors |
| 02/24/2011 | CA2769415A1 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| 02/23/2011 | EP2287288A1 Animal protein free media for cultivation of cells |
| 02/23/2011 | EP2286841A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/23/2011 | EP2285964A1 Phage lambda display constructs |
| 02/23/2011 | EP2285952A2 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 02/23/2011 | EP1801209B1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 02/23/2011 | EP1090108B1 Novel methods for rescue of rna viruses |
| 02/23/2011 | CN101981182A Genetically modified attenuated vesicular stomatitis virus, compositions and methods of use therof |
| 02/23/2011 | CN101979598A Method for constructing HSV-1 BAC system carrying luciferase report genes |
| 02/23/2011 | CN101979549A Gene medicament taking voltage-gated proton channel Hv1 as targeted locus for treatment of breast cancer |
| 02/23/2011 | CN101979520A Core-binding factor alpha1 gene recombinant virus for specifically promoting cartilage differentiation, preparation method and application thereof |
| 02/23/2011 | CN101979519A Method for preparing pseudorabies vaccines |
| 02/23/2011 | CN101979518A Method for preparing pseudorabies virus |
| 02/23/2011 | CN101979517A Method for producing influenza viruses in large scale by using bioreactor |
| 02/23/2011 | CN101979516A Virus sampling liquid composition |
| 02/23/2011 | CN101979515A Animal rabies virus and vaccine and production method thereof |
| 02/23/2011 | CN101979514A Virus and vaccine of porcine reproductive and respiratory syndrome and preparation method of same |
| 02/23/2011 | CN101979513A Duck-origin paramyxovirus attenuated lapinized Chineses (LC) strain and application thereof to the preparation of vaccines |
| 02/23/2011 | CN101220349B Separated coliphage and application as biological fungicide in foods and anti-infection contamination thereof |
| 02/22/2011 | US7893007 Directed evolution of novel binding proteins |
| 02/22/2011 | US7892822 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |
| 02/22/2011 | US7892809 Adeno-associated virus (AAV); genetic engineering; parvoviruses; gene therapy; muscle delivery; glioblastoma; Parkinson's Disease |
| 02/22/2011 | US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system |
| 02/22/2011 | US7892726 Method for sterilizing lyophilized eukaryotic anuclear cells with gamma irradiation |
| 02/22/2011 | US7892564 Recombinant infectious laryngotracheitis virus and uses thereof |
| 02/22/2011 | US7892562 Methods of inducing TH-1 immune responses to HIV-1 by administering UV/psoralen-treated desialated inactiviated HIV-1 virions deficient in CD55 and CD59 |
| 02/22/2011 | US7892533 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/22/2011 | CA2423833C Viruses targeted to hypoxic cells and tissues |
| 02/22/2011 | CA2399504C Methods for producing temperature-sensitive morbillivirus |
| 02/17/2011 | WO2011019827A2 Phage displaying system expressing single chain antibody |
| 02/17/2011 | WO2011018702A1 A method of producing virus-like particles |
| 02/17/2011 | WO2010146043A3 System for the heterologous expression of a viral protein in a ciliate host cell |
| 02/17/2011 | WO2010135054A3 Mutations in a toll-like receptor motif in the ns4b of classical swine fever virus skin brescia influences virulence in swine |
| 02/17/2011 | US20110041222 Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants |
| 02/17/2011 | US20110039916 Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof |
| 02/17/2011 | US20110038890 Cellular And Viral Inactivation |
| 02/17/2011 | US20110038886 N-Linked Glycosylation Alteration in E0 and E2 Glycoprotein of Classical Swine Fever Virus and Novel Classical Swine Fever Virus Vaccine |
| 02/16/2011 | EP2284180A2 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 02/16/2011 | EP2283859A2 Pantropic canine coronavirus |
| 02/16/2011 | EP2283858A2 West Nile Vaccine |
| 02/16/2011 | EP2283026A1 Method for concentrating and isolating biomolecules or viruses |
| 02/16/2011 | EP1469077B1 Cell-specific expression/replication vector |
| 02/16/2011 | EP0871754B1 Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| 02/16/2011 | CN101978066A Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 02/16/2011 | CN101974563A Expression vector of grass carp bleeding disease vaccine protein and constructing method thereof |
| 02/16/2011 | CN101974545A Method for massively expressing wild silkworm anti-viral protein SP-2 |
| 02/16/2011 | CN101974490A Method for purifying swine fever viruses |
| 02/16/2011 | CN101974489A A H1N1 influenza virus and application thereof |
| 02/16/2011 | CN101974078A Protein for detecting H1 hypotype swine influenza virus antibodies and application thereof |
| 02/15/2011 | US7888472 Optimized multi-epitope constructs and uses thereof |
| 02/15/2011 | US7888458 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 02/15/2011 | US7888102 Cell line for producing coronaviruses |
| 02/15/2011 | US7888098 Scalable process for protein purification |
| 02/15/2011 | US7888097 Formulation for adenovirus storage |
| 02/15/2011 | US7888096 Liquid adenovirus formulations |
| 02/15/2011 | CA2439067C Lentiviral packaging constructs |
| 02/15/2011 | CA2433071C Use of transcription factor yb-1 in adenoviral systems |
| 02/15/2011 | CA2347084C Hepatitis a vaccines |
| 02/10/2011 | WO2009158618A8 Avian reoviridae |
| 02/10/2011 | US20110034370 Bis-met histones |
| 02/10/2011 | US20110033838 Surface antigen protein mutant of hepatitis b virus surface antigen |
| 02/10/2011 | US20110033498 METHODS OF PREVENTING AND TREATING VIRAL INFECTIONS BY INHIBITING THE DelSGYLATION ACTIVITY OF OTU DOMAIN-CONTAINING VIRAL PROTEINS |
| 02/10/2011 | US20110033425 Parvovirus Having a CPG-Enriched Genome Useful for Cancer Therapy |
| 02/10/2011 | US20110033424 Use of adenovirus and nucleic acids coding therefor |
| 02/09/2011 | EP2281897A2 Oncolytic mutant Herpes Simplex virus |
| 02/09/2011 | EP2281882A1 Nucleic acid containing chimeric gene derived from hepatitis type-c virus |
| 02/09/2011 | EP2281877A2 Methods for producing preparations of recombinant AAV virions substantially free of empty capsids |
| 02/09/2011 | EP2281573A2 Influenza vaccine formulations for intradermal delivery |
| 02/09/2011 | EP2281572A1 West Nile Vaccine |
| 02/09/2011 | EP2281033A1 Post release modification of viral envelopes |
| 02/09/2011 | EP2280727A1 Vaccine compositions for the treatment of dengue fever and uses thereof |
| 02/09/2011 | CN1894400B Serum-free VERO cell banking process |
| 02/09/2011 | CN101970645A Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 02/09/2011 | CN101970644A Novel bacteriophage and antibacterial composition comprising the same |
| 02/09/2011 | CN101970467A Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines |
| 02/09/2011 | CN101967683A Storage method and screening method of metagenomic libraries |
| 02/09/2011 | CN101967466A ORF7 auxotrophic varicella virus strain, vaccine containing same and application thereof |
| 02/09/2011 | CN101967186A Encephalitis virus protein and code gene and application thereof |
| 02/09/2011 | CN101967185A Encephalitis virus protein as well as coding gene and application thereof |
| 02/09/2011 | CN101358202B Recombinant canine adenovirus type 2 transfer vector, construction method and application thereof |
| 02/08/2011 | USRE42129 DNA based tests for the presence of the obesity associated virus adenovirus type 36; for reducing levels of triglycerides and cholesterol in humans |
| 02/08/2011 | US7884199 HCV NS3-NS4 protease resistance mutants |
| 02/08/2011 | US7883884 anaerobic digestion of animal manures, energy crops and similar organic substrates to refine nutrients comprised in the digested biomass to fertilizers of commercial quality; processing the organic waste material of animal origin; increased hygiene and food safety; BSE |
| 02/08/2011 | CA2419822C Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 02/08/2011 | CA2320419C Compositions comprising viruses and methods for concentrating virus preparations |
| 02/08/2011 | CA2296797C Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/08/2011 | CA2273825C Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 02/03/2011 | WO2011014693A2 Bacteriophages expressing amyloid peptides and uses thereof |
| 02/03/2011 | WO2011014645A1 Influenza viruses and uses thereof |
| 02/03/2011 | WO2011014504A1 Recombinant influenza virus vectors and uses thereof |
| 02/03/2011 | WO2011012999A1 Reverse genetics systems |
| 02/03/2011 | WO2011011971A1 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof |
| 02/03/2011 | US20110028537 Somatic cell reprogramming |
| 02/03/2011 | US20110027863 Laboratory vessel with shiftable vessel closure |
| 02/03/2011 | US20110027862 Sample stabilization |
| 02/03/2011 | US20110027861 Desiccated Biologics And Methods Of Preparing The Same |
| 02/03/2011 | US20110027800 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings |
| 02/03/2011 | US20110027319 Methods of eliciting or boosting a cellular immune response |